These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Therapy with rituximab for autoimmune pemphigus: results from a single-center observational study on 42 cases with long-term follow-up. Cianchini G, Lupi F, Masini C, Corona R, Puddu P, De Pità O. J Am Acad Dermatol; 2012 Oct; 67(4):617-22. PubMed ID: 22243765 [Abstract] [Full Text] [Related]
7. Clinical experiences of different dosing schedules of rituximab in pemphigus with various disease severities. Cho HH, Jin SP, Chung JH. J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):186-91. PubMed ID: 23356542 [Abstract] [Full Text] [Related]
8. Rituximab treatment of severe pemphigus: long-term results including immunologic follow-up. Reguiai Z, Tabary T, Maizières M, Bernard P. J Am Acad Dermatol; 2012 Oct; 67(4):623-9. PubMed ID: 22261417 [Abstract] [Full Text] [Related]
9. Rituximab for the treatment of corticosteroid-refractory pemphigus vulgaris with oral and skin manifestations. Craythorne E, du Viver A, Mufti GJ, Warnakulasuriya S. J Oral Pathol Med; 2011 Sep; 40(8):616-20. PubMed ID: 21385212 [Abstract] [Full Text] [Related]
10. Is it time to re-evaluate the treatment of pemphigus? Leventhal JS, Sanchez MR. J Drugs Dermatol; 2012 Oct; 11(10):1200-6. PubMed ID: 23134985 [Abstract] [Full Text] [Related]
12. Comparison of immunological parameters in patients with pemphigus vulgaris following rituximab and IVIG therapy. Feldman RJ, Christen WG, Ahmed AR. Br J Dermatol; 2012 Mar; 166(3):511-7. PubMed ID: 21967407 [Abstract] [Full Text] [Related]
13. Efficacy and safety of rituximab treatment in Indian pemphigus patients. Kanwar AJ, Tsuruta D, Vinay K, Koga H, Ishii N, Dainichi T, Hashimoto T. J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e17-23. PubMed ID: 22176540 [Abstract] [Full Text] [Related]
14. Clinical efficacy of different doses of rituximab in the treatment of pemphigus: a retrospective study of 27 patients. Kim JH, Kim YH, Kim MR, Kim SC. Br J Dermatol; 2011 Sep; 165(3):646-51. PubMed ID: 21574976 [Abstract] [Full Text] [Related]
16. Treatment of severe pemphigus with rituximab: report of 12 cases and a review of the literature. Cianchini G, Corona R, Frezzolini A, Ruffelli M, Didona B, Puddu P. Arch Dermatol; 2007 Aug; 143(8):1033-8. PubMed ID: 17709662 [Abstract] [Full Text] [Related]
18. Intermediate doses of rituximab used as adjuvant therapy in refractory pemphigus. Londhe PJ, Kalyanpad Y, Khopkar US. Indian J Dermatol Venereol Leprol; 2014 Aug; 80(4):300-5. PubMed ID: 25035353 [Abstract] [Full Text] [Related]
19. Efficacy and safety of rituximab in pemphigus: experience of the German Registry of Autoimmune Diseases. Kasperkiewicz M, Eming R, Behzad M, Hunzelmann N, Meurer M, Schulze-Koops H, von Wussow P, Hertl M, Zillikens D, Freivogel K, Dörner T, Schmidt E. J Dtsch Dermatol Ges; 2012 Oct; 10(10):727-32. PubMed ID: 22577946 [Abstract] [Full Text] [Related]
20. Two courses of rituximab (anti-CD20 monoclonal antibody) for recalcitrant pemphigus vulgaris. Faurschou A, Gniadecki R. Int J Dermatol; 2008 Mar; 47(3):292-4. PubMed ID: 18289336 [Abstract] [Full Text] [Related] Page: [Next] [New Search]